<DOC>
	<DOC>NCT01858636</DOC>
	<brief_summary>To characterize the clinical outcomes of Angio-Seal VIP with St. Jude Medical (SJM) collagen through the collection of device/procedure-related major vascular complications and time to hemostasis.</brief_summary>
	<brief_title>Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device</brief_title>
	<detailed_description />
	<criteria>Patient requires closure of femoral artery puncture resulting from arterial access procedure. Patient is ≥18 years of age. Patient is willing to provide written informed consent prior to study device use. Patient is willing and able to adhere to data collection and followup requirements. Patient is participating in another clinical trial which has the potential to impact hemostasis. Patient has an active groin infection or systemic infection. Patient has undergone a vascular access procedure within the past 90 days. Patient has been previously enrolled in the study. (For patients undergoing multiple interventions within a timeframe of 90 days, only the initial procedure may constitute a study enrollment.)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>